Skip to main content

Published locations for Two-year dupilumab data: Continued response for moderate to severe pediatric asthma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Two-year dupilumab data: Continued response for moderate to severe pediatric asthma

User login

  • Reset your password
  • /content/two-year-dupilumab-data-continued-response-moderate-severe-pediatric-asthma
  • /familypracticenews/article/258924/asthma/two-year-dupilumab-data-continued-response-moderate-severe
  • /pediatricnews/article/258924/asthma/two-year-dupilumab-data-continued-response-moderate-severe
  • /pediatrics/article/258924/asthma/two-year-dupilumab-data-continued-response-moderate-severe
  • /familymedicine/article/258924/asthma/two-year-dupilumab-data-continued-response-moderate-severe
  • /chestphysician/article/258924/asthma/two-year-dupilumab-data-continued-response-moderate-severe